I see people get “stuck” near the end of their taper, experiencing those interdosing withdrawal symptoms, not being able to cut down to the next dose and that’s where I see NAD+ IV therapy do a lot for people. We currently offer NAD+ IV in Sedona, AZ at Alternative to Meds Cente...
A phase I trial of GMX1777, an inhibitor of nicotinamide phosphoribosyl transferase (NAMPRT), given as a 24-hour infusion. J. Clin. Oncol. 2009, 27, 3581. [Google Scholar] [CrossRef] Naing, A.; Leong, S.; Pishvaian, M.J.; Razak, A.R.A.; Mahipal, A.; Berlin, J.; Cho, ...